Questo sito utilizza i cookies tecnici per agevolarti nella navigazione, non raccoglie in nessun modo dati sensibili o finalizzati ad alcun tipo di profilazione, gli unici dati raccolti sono esclusivamente a scopo statistico tramite il plugin di Google Analitics, al quale è comunque negato il consenso alla raccolta e archiviazione dei dati per fini di profilazione o qualunque altro scopo. Se non sei d'accordo, ti preghiamo di chiudere immediatamente la pagina.

Carone Marinella

Dettagli
Visite: 49

Research scientist
c/o Università di Milano - Bicocca
Via Raoul Follereau, 3
20854 Vedano al Lambro (MB)

Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.

 

Gene therapy represents one of the most promising frontiers for neurological diseases that have long been considered untreatable. This conviction has shaped my scientific path since my PhD at the University of Brescia, where I investigated cannabinoid therapies and gene-editing strategies in mouse models of neurodevelopmental disorders. A research stay at University College London allowed me to deepen my expertise in CRISPR/Cas9 approaches, working on the precise modeling of disease-relevant mutations.
After my PhD, I joined a gene therapy centre at the University of Barcelona, where I contributed to developing an AAV-based platform for BDNF brain delivery in Huntington's disease, an experience that brought me closer to the translational challenges of working with viral vectors and human iPSCs.
I am now a postdoctoral researcher in the Luoni lab at the CNR Institute of Neuroscience in Milan, where I work on gene correction strategies for Rett syndrome, focusing on the role of MeCP2 and the development of in vitro and in vivo models to test new therapeutic approaches. My work sits at the intersection of basic and translational neuroscience, with the shared goal of turning precise genetic tools into real treatments for patients.